Your browser doesn't support javascript.
loading
Effect-enhancing and toxicity-reducing activity of usnic acid in ascitic tumor-bearing mice treated with bleomycin.
Su, Zu-Qing; Liu, Yu-Hong; Guo, Hui-Zhen; Sun, Chao-Yue; Xie, Jian-Hui; Li, Yu-Cui; Chen, Jian-Nan; Lai, Xiao-Ping; Su, Zi-Ren; Chen, Hai-Ming.
Afiliação
  • Su ZQ; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
  • Liu YH; Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Guo HZ; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center of Sun Yat-sen University, Guangzhou 510060, China.
  • Sun CY; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
  • Xie JH; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
  • Li YC; Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Chen JN; Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Dongguan Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Donggu
  • Lai XP; Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Dongguan Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Donggu
  • Su ZR; Guangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Dongguan Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Donggu
  • Chen HM; Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510120, China; Postdoctoral Programme, Guangzhou University of Chinese Medicine, Guangzhou 510120, China. Electronic address
Int Immunopharmacol ; 46: 146-155, 2017 May.
Article em En | MEDLINE | ID: mdl-28284148
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Ascite / Fibrose Pulmonar / Benzofuranos / Carcinoma Hepatocelular / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Etiology_studies Limite: Animals / Humans / Male Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Ascite / Fibrose Pulmonar / Benzofuranos / Carcinoma Hepatocelular / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Etiology_studies Limite: Animals / Humans / Male Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2017 Tipo de documento: Article